bupropion has been researched along with mecamylamine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 13 (72.22) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frølund, B; Jensen, AA; Krogsgaard-Larsen, P; Liljefors, T | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hurt, RD | 1 |
| Damaj, MI; Lavecchia, KL; Martin, BR; Wiley, JL | 1 |
| Glennon, RA; Young, R | 1 |
| Dwoskin, LP; Miller, DK; Sumithran, SP | 1 |
| Roddy, E | 1 |
| Glick, SD; Maisonneuve, IM; Panchal, V; Taraschenko, OD | 1 |
| Bevins, RA; Palmatier, MI; Siebert, HL; Wilkinson, JL; Wiltgen, SM | 1 |
| Erwin, DS; Jennings, RE; Khambati, HN; Lake, JR; Malin, DH; Meyers-Paal, RL; Montellano, AL; Perales, BA; Presley, SE; Smith, TD | 1 |
| James, JR; Philibin, SD; Robinson, SE; Rosecrans, JA; Vann, RE | 1 |
| Shoaib, M; Wing, VC | 1 |
| Rose, JE | 1 |
| Caggiula, AR; Donny, EC; Levin, ME; Mays, KL; Palmatier, MI; Sved, AF | 1 |
| Ebbert, JO; Elrashidi, MY | 1 |
| Biała, G; Budzyńska, B; Kruk-Słomka, M; Michalak, A | 1 |
| Buoli, M; Cahn, W; Serati, M | 1 |
7 review(s) available for bupropion and mecamylamine
| Article | Year |
|---|---|
Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations.
Topics: Allosteric Regulation; Amino Acid Sequence; Animals; Humans; Ligands; Mice; Mice, Knockout; Models, Molecular; Molecular Sequence Data; Nicotinic Agonists; Nicotinic Antagonists; Protein Conformation; Protein Subunits; Receptors, Nicotinic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New medications for nicotine dependence treatment.
Topics: Administration, Cutaneous; Administration, Inhalation; Bupropion; Chewing Gum; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Mecamylamine; Nicotine; Nicotinic Antagonists; Smoking; Smoking Cessation; Tobacco Use Disorder | 1999 |
Bupropion and other non-nicotine pharmacotherapies.
Topics: Administration, Inhalation; Adrenergic alpha-Agonists; Antidepressive Agents, Second-Generation; Bupropion; Clonidine; Dopamine Uptake Inhibitors; Drug Interactions; Humans; Mecamylamine; Nicotine; Nicotinic Antagonists; Smoking Cessation | 2004 |
New findings on nicotine addiction and treatment.
Topics: Animals; Benzazepines; Bupropion; Humans; Mecamylamine; Motivation; Nicotine; Nicotinic Antagonists; Quinoxalines; Reward; Smoking Cessation; Tobacco Use Disorder; Vaccines; Varenicline | 2009 |
Emerging drugs for the treatment of tobacco dependence: 2014 update.
Topics: Atomoxetine Hydrochloride; Benzazepines; Bupropion; Clinical Trials as Topic; Clonidine; Humans; Mecamylamine; Nicotine; Nortriptyline; Propylamines; Quinoxalines; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2014 |
Alternative pharmacological strategies for adult ADHD treatment: a systematic review.
Topics: Adrenergic alpha-Agonists; Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Central Nervous System Stimulants; Desipramine; Dopamine Agents; Droxidopa; Drug Combinations; Duloxetine Hydrochloride; Guanfacine; Histamine Agents; Humans; Lisdexamfetamine Dimesylate; Lithium Compounds; Lobeline; Mecamylamine; Memantine; Modafinil; Morpholines; Nicotinic Agonists; Nicotinic Antagonists; Nomifensine; Paroxetine; Pyridines; Pyridoxine; Pyrrolidonecarboxylic Acid; Quinazolinones; Reboxetine; Venlafaxine Hydrochloride; Wakefulness-Promoting Agents | 2016 |
11 other study(ies) available for bupropion and mecamylamine
| Article | Year |
|---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Nicotine-like discriminative stimulus effects of bupropion in rats.
Topics: Animals; Bupropion; Discrimination, Psychological; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Long-Evans | 2002 |
Nicotine and bupropion share a similar discriminative stimulus effect.
Topics: Animals; Antidepressive Agents; Bupropion; Central Nervous System Stimulants; Discrimination Learning; Dose-Response Relationship, Drug; Generalization, Stimulus; Injections, Subcutaneous; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Smoking Cessation | 2002 |
Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
Topics: Animals; Bupropion; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Electric Stimulation; Hippocampus; In Vitro Techniques; Kinetics; Male; Mecamylamine; Membrane Glycoproteins; Membrane Transport Proteins; Neostriatum; Nerve Tissue Proteins; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nomifensine; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Symporters | 2002 |
Is antagonism of alpha3beta4 nicotinic receptors a strategy to reduce morphine dependence?
Topics: Acute Disease; Animals; Bupropion; Dextromethorphan; Drug Therapy, Combination; Female; Mecamylamine; Morphine Dependence; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Substance Withdrawal Syndrome | 2005 |
Characterization of nicotine's ability to serve as a negative feature in a Pavlovian appetitive conditioning task in rats.
Topics: Amphetamine; Animals; Arecoline; Association Learning; Bupropion; Caffeine; Chlordiazepoxide; Conditioning, Classical; Conditioning, Operant; Discrimination Learning; Dose-Response Relationship, Drug; Drug Interactions; Hexamethonium; Male; Mecamylamine; Motor Activity; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Reinforcement, Psychology; Sucrose | 2006 |
Bupropion attenuates nicotine abstinence syndrome in the rat.
Topics: Animals; Association Learning; Avoidance Learning; Bupropion; Conditioning, Classical; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Premedication; Rats; Rats, Sprague-Dawley; Social Environment; Substance Withdrawal Syndrome | 2006 |
Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
Topics: Animals; Behavior, Animal; Brain; Brain Chemistry; Bupropion; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Presynaptic Terminals; Rats; Rats, Inbred F344; Receptors, Nicotinic; Reinforcement, Psychology; Rubidium Radioisotopes; Tobacco Use Disorder | 2006 |
Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal.
Topics: Animals; Antidepressive Agents; Bupropion; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mecamylamine; Nicotine; Nortriptyline; Rats; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2007 |
Bupropion and nicotine enhance responding for nondrug reinforcers via dissociable pharmacological mechanisms in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Bupropion; Conditioning, Operant; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Mecamylamine; Motivation; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Prazosin; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Reward; Time Factors | 2009 |
A comparison of mecamylamine and bupropion effects on memory-related responses induced by nicotine and scopolamine in the novel object recognition test in mice.
Topics: Analysis of Variance; Animals; Bupropion; Cholinergic Agents; Dose-Response Relationship, Drug; Exploratory Behavior; Male; Mecamylamine; Memory; Mice; Nicotine; Pattern Recognition, Visual; Scopolamine | 2014 |